Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
12 NEW March 20, 2023
ASCO 2022: Equity, innovation and in-person

ASCO 2022: Equity, innovation and in-person

Hutch cancer researchers, clinicians share findings on clinical trial eligibility, Medicaid expansion, wearables to track symptoms and more
Hutch News - June 09, 2022
New study: Financial hardship common with metastatic colorectal cancer

New study: Financial hardship common with metastatic colorectal cancer

Despite health insurance, almost three-fourths of these patients experienced financial hardship within first year after diagnosis
Hutch News - January 06, 2022
What’s new in breast cancer research? SABCS20 goes virtual

What’s new in breast cancer research? SABCS20 goes virtual

Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
Hutch News - December 18, 2020
High impact of positive and negative clinical trial results

High impact of positive and negative clinical trial results

From the Unger Group, Division of Public Health Sciences
Science Spotlight - October 21, 2019
Dr. James Dai receives $2.1M NCI grant for cancer biomarker research

Dr. James Dai receives $2.1M NCI grant for cancer biomarker research

Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment
Hutch News - August 20, 2018
Closing the rural-urban cancer survival gap

Closing the rural-urban cancer survival gap

‘Guideline care’ in clinical trials erased cancer death-rate disparities
Hutch News - August 17, 2018
Cancer clinical trials: In defense of the negative result

Cancer clinical trials: In defense of the negative result

Large cancer clinical trials that ‘fail’ carry just as much scientific oomph as positive findings, new study shows
Hutch News - March 10, 2016